HUMA
Humacyte Inc

7,732
Mkt Cap
$316.49M
Volume
2.68M
52W High
$6.77
52W Low
$1.15
PE Ratio
-3.70
HUMA Fundamentals
Price
$1.71
Prev Close
$1.69
Open
$1.72
50D MA
$1.67
Beta
1.80
Avg. Volume
3.14M
EPS (Annual)
-$1.26
P/B
65.20
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Humacyte, Inc. (HUMA) Laps the Stock Market: Here's Why
Humacyte, Inc. (HUMA) closed at $1.72 in the latest trading session, marking a +1.18% move from the prior day.
Zacks·7d ago
News Placeholder
More News
News Placeholder
Humacyte, Inc. (HUMA) Advances While Market Declines: Some Information for Investors
The latest trading day saw Humacyte, Inc. (HUMA) settling at $1.79, representing a +1.7% change from its previous close.
Zacks·10d ago
News Placeholder
Humacyte, Inc. (HUMA) Declines More Than Market: Some Information for Investors
In the most recent trading session, Humacyte, Inc. (HUMA) closed at $1.65, indicating a -33.67% shift from the previous trading day.
Zacks·17d ago
News Placeholder
Humacyte, Inc. (HUMA) Outperforms Broader Market: What You Need to Know
Humacyte, Inc. (HUMA) concluded the recent trading session at $1.76, signifying a +1.15% move from its prior day's close.
Zacks·23d ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Drops Despite Market Gains: Important Facts to Note
Humacyte, Inc. (HUMA) concluded the recent trading session at $1.77, signifying a -4.84% move from its prior day's close.
Zacks·1mo ago
News Placeholder
Is It Worth Investing in Humacyte, Inc. (HUMA) Based on Wall Street's Bullish Views?
According to the average brokerage recommendation (ABR), one should invest in Humacyte, Inc. (HUMA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
Zacks·2mo ago
News Placeholder
Humacyte, Inc. (HUMA) Reports Q2 Loss, Misses Revenue Estimates
Humacyte, Inc. (HUMA) delivered earnings and revenue surprises of -60.00% and -73.60%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·2mo ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts
Humacyte, Inc. (HUMA) concluded the recent trading session at $2.21, signifying a -4.33% move from its prior day's close.
Zacks·3mo ago
News Placeholder
Humacyte, Inc. (HUMA) Suffers a Larger Drop Than the General Market: Key Insights
Humacyte, Inc. (HUMA) closed at $2.4 in the latest trading session, marking a -1.23% move from the prior day.
Zacks·3mo ago
News Placeholder
Humacyte, Inc. (HUMA) Stock Dips While Market Gains: Key Facts
Humacyte, Inc. (HUMA) concluded the recent trading session at $2.53, signifying a -5.24% move from its prior day's close.
Zacks·3mo ago

Latest HUMA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.